MTOR and hepatocellular carcinoma: Although the expression of galectin-3 was reported to be higher in HCC than non-cancerous tissues, and to associate with a poor prognosis,19–21 the relationship between mTOR signaling, galectin-3 and M2BPGi in HCC remains unknown.